1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Microalbuminuria Global Clinical Trials Review, H1, 2015

Microalbuminuria Global Clinical Trials Review, H1, 2015

  • January 2015
  • -
  • Global Data
  • -
  • 86 pages

Microalbuminuria Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Microalbuminuria Global Clinical Trials Review, H1, 2015" provides data on the Microalbuminuria clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Microalbuminuria. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Microalbuminuria. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Microalbuminuria Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 6
Microalbuminuria 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Microalbuminuria 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Microalbuminuria Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Steno Diabetes Center A/S 33
Clinical Trial Overview of Steno Diabetes Center A/S 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Takeda Pharmaceutical Company Limited 35
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 35
Sanofi 36
Clinical Trial Overview of Sanofi 36
Bristol-Myers Squibb Company 37
Clinical Trial Overview of Bristol-Myers Squibb Company 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Keryx Biopharmaceuticals, Inc. 39
Clinical Trial Overview of Keryx Biopharmaceuticals, Inc. 39
GlaxoSmithKline plc 40
Clinical Trial Overview of GlaxoSmithKline plc 40
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
Clinical Trial Overview of Top Institutes / Government 42
Hospital de Clinicas de Porto Alegre 42
Clinical Trial Overview of Hospital de Clinicas de Porto Alegre 42
University Medical Center Groningen 43
Clinical Trial Overview of University Medical Center Groningen 43
Shiga University of Medical Science 44
Clinical Trial Overview of Shiga University of Medical Science 44
Juntendo University School of Medicine 45
Clinical Trial Overview of Juntendo University School of Medicine 45
University Medical Centre Ljubljana 46
Clinical Trial Overview of University Medical Centre Ljubljana 46
University of Pavia 47
Clinical Trial Overview of University of Pavia 47
Postgraduate Institute of Medical Education and Research 48
Clinical Trial Overview of Postgraduate Institute of Medical Education and Research 48
University of Campinas, Brazil 49
Clinical Trial Overview of University of Campinas, Brazil 49
Seoul National University Hospital 50
Clinical Trial Overview of Seoul National University Hospital 50
Akershus University Hospital 51
Clinical Trial Overview of Akershus University Hospital 51
Five Key Clinical Profiles 52
Appendix 84
Abbreviations 84
Definitions 84
Research Methodology 85
Secondary Research 85
About GlobalData 86
Contact Us 86
Disclaimer 86
Source 86

List of Tables

Microalbuminuria Therapeutics, Global, Clinical Trials by Region, 2015* 7
Microalbuminuria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Microalbuminuria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Microalbuminuria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Microalbuminuria Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Microalbuminuria Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Microalbuminuria Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Microalbuminuria Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Microalbuminuria Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Microalbuminuria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Microalbuminuria Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Microalbuminuria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Microalbuminuria Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Microalbuminuria Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Microalbuminuria Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Microalbuminuria Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Microalbuminuria Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Microalbuminuria Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Microalbuminuria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Microalbuminuria Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Microalbuminuria Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Microalbuminuria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Microalbuminuria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Steno Diabetes Center A/S, 2015* 33
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 34
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 35
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 36
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 37
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 38
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Keryx Biopharmaceuticals, Inc., 2015* 39
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 40
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 41
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital de Clinicas de Porto Alegre, 2015* 42
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2015* 43
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiga University of Medical Science, 2015* 44
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015* 45
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Centre Ljubljana, 2015* 46
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pavia, 2015* 47
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2015* 48
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Campinas, Brazil, 2015* 49
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 50
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Akershus University Hospital, 2015* 51

List of Figures

Microalbuminuria Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Microalbuminuria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Microalbuminuria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Microalbuminuria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Microalbuminuria Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Microalbuminuria Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Microalbuminuria Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Microalbuminuria Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Microalbuminuria Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Microalbuminuria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Microalbuminuria Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Microalbuminuria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Microalbuminuria Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Microalbuminuria Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Microalbuminuria Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Microalbuminuria Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Microalbuminuria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Microalbuminuria Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Microalbuminuria Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Microalbuminuria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Microalbuminuria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 85

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.